Hulio™ is a medicine to fight Autoimmune conditions. Certain medicines like
adalimumab are based on large complex substances from the human body, so it is impossible to make
exact copies. However, it is possible to make a drug called a biosimilar, which must go through a very
comprehensive testing process to show that it does not to have any clinically meaningful differences from
the reference product in terms of quality, safety and efficacy.
▼ This medicine is subject to additional monitoring. This will allow quick identification of new safety
information. You can help by reporting any side effects you may get. If you get any side effects talk to your
doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. See
for how to report side effects. By reporting side effects you can help provide
more information on the safety of this medicine.
DOP: November 2018